Cibus launches IPO to further develop its non-GM gene editing technology

November 21, 2018 |

In California, Cibus Ltd announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of Cibus common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Cibus intends to list its common stock on the Nasdaq Global Market under the trading symbol “CBUS.”

Cibus is a biotechnology company using advanced technologies to develop desirable plant traits for the global seed industry by precisely editing a plant’s genes without the integration of foreign genetic material. This technique accelerates natural breeding that has been a staple of farming for thousands of years and has been classified in certain key agricultural markets as not subject to GMO regulation. Cibus has launched its first commercial canola product, Falco™, and is developing a pipeline of beneficial traits in other crops that it plans to license, including healthier oil quality, disease resistance, and herbicide tolerance. Cibus has established crop platforms in canola, rice, flax, potato, and is now developing platforms in wheat, corn, soybean and peanut.

Category: Fuels

Thank you for visting the Digest.